(Total Views: 619)
Posted On: 10/30/2022 12:00:54 PM
Post# of 155806
Agree but if the new trials are with BP and a partner it does them no good to slow play us at this point .
Nash could be approved in 3 years. The problem is Nash is a tall order. There are zero drugs approved for this. A cancer drug could be approved sooner but we still don’t know if we have to do a phase 2 again ?
Nash could be approved in 3 years. The problem is Nash is a tall order. There are zero drugs approved for this. A cancer drug could be approved sooner but we still don’t know if we have to do a phase 2 again ?
(0)
(0)
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
